REPORT ID 13788

United States Cardiac Troponin Market Report 2017

Publish Date
22-Nov-17
Pages
104
Format
Electronic (PDF)

In this report, the United States Cardiac Troponin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Cardiac Troponin in these regions, from 2012 to 2022 (forecast).

United States Cardiac Troponin market competition by top manufacturers/players, with Cardiac Troponin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott
    Roche
    Biomerieux SA
    BG Medicine
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    cTn T
    cTn I
    TnC
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Cardiac Troponin Market Report 2017
1 Cardiac Troponin Overview
    1.1 Product Overview and Scope of Cardiac Troponin
    1.2 Classification of Cardiac Troponin by Product Category
        1.2.1 United States Cardiac Troponin Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Cardiac Troponin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 cTn T
        1.2.4 cTn I
        1.2.5 TnC
    1.3 United States Cardiac Troponin Market by Application/End Users
        1.3.1 United States Cardiac Troponin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Others
    1.4 United States Cardiac Troponin Market by Region
        1.4.1 United States Cardiac Troponin Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Cardiac Troponin Status and Prospect (2012-2022)
        1.4.3 Southwest Cardiac Troponin Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Cardiac Troponin Status and Prospect (2012-2022)
        1.4.5 New England Cardiac Troponin Status and Prospect (2012-2022)
        1.4.6 The South Cardiac Troponin Status and Prospect (2012-2022)
        1.4.7 The Midwest Cardiac Troponin Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Cardiac Troponin (2012-2022)
        1.5.1 United States Cardiac Troponin Sales and Growth Rate (2012-2022)
        1.5.2 United States Cardiac Troponin Revenue and Growth Rate (2012-2022)

2 United States Cardiac Troponin Market Competition by Players/Suppliers
    2.1 United States Cardiac Troponin Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Cardiac Troponin Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Cardiac Troponin Average Price by Players/Suppliers (2012-2017)
    2.4 United States Cardiac Troponin Market Competitive Situation and Trends
        2.4.1 United States Cardiac Troponin Market Concentration Rate
        2.4.2 United States Cardiac Troponin Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Cardiac Troponin Manufacturing Base Distribution, Sales Area, Product Type

3 United States Cardiac Troponin Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Cardiac Troponin Sales and Market Share by Region (2012-2017)
    3.2 United States Cardiac Troponin Revenue and Market Share by Region (2012-2017)
    3.3 United States Cardiac Troponin Price by Region (2012-2017)

4 United States Cardiac Troponin Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Cardiac Troponin Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Cardiac Troponin Revenue and Market Share by Type (2012-2017)
    4.3 United States Cardiac Troponin Price by Type (2012-2017)
    4.4 United States Cardiac Troponin Sales Growth Rate by Type (2012-2017)

5 United States Cardiac Troponin Sales (Volume) by Application (2012-2017)
    5.1 United States Cardiac Troponin Sales and Market Share by Application (2012-2017)
    5.2 United States Cardiac Troponin Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Cardiac Troponin Players/Suppliers Profiles and Sales Data
    6.1 Abbott
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Cardiac Troponin Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Abbott Cardiac Troponin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Roche
        6.2.2 Cardiac Troponin Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Roche Cardiac Troponin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Biomerieux SA
        6.3.2 Cardiac Troponin Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Biomerieux SA Cardiac Troponin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 BG Medicine
        6.4.2 Cardiac Troponin Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 BG Medicine Cardiac Troponin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    ...

7 Cardiac Troponin Manufacturing Cost Analysis
    7.1 Cardiac Troponin Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Cardiac Troponin

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Cardiac Troponin Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Cardiac Troponin Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Cardiac Troponin Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Cardiac Troponin Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Cardiac Troponin Sales Volume Forecast by Type (2017-2022)
    11.3 United States Cardiac Troponin Sales Volume Forecast by Application (2017-2022)
    11.4 United States Cardiac Troponin Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer